Literature DB >> 11561154

Core binding factor and its role in normal hematopoietic development.

N A Speck1.   

Abstract

The core binding factors are a small family of transcription factors comprising a DNA binding CBFalpha subunit and a non-DNA binding CBFbeta subunit. One gene encoding a CBFalpha subunit, RUNX1 (also known as AML1, CBFA2, and PEBPA2A), and the gene encoding CBFbeta (CBFB) are essential for hematopoiesis and are frequently mutated in human leukemias. Both genes are required for the generation of hematopoietic stem cells (HSCs) during embryonic development. Expression studies in fish and frogs and functional analyses in flies indicate that a role for these genes in hematopoiesis is evolutionarily conserved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561154     DOI: 10.1097/00062752-200107000-00002

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  26 in total

1.  The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.

Authors:  Rachit Bakshi; Mohammad Q Hassan; Jitesh Pratap; Jane B Lian; Martin A Montecino; Andre J van Wijnen; Janet L Stein; Anthony N Imbalzano; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 2.  Core binding factor acute myeloid leukemia: Advances in the heterogeneity of KIT, FLT3, and RAS mutations (Review).

Authors:  Xi Quan; Jianchuan Deng
Journal:  Mol Clin Oncol       Date:  2020-05-25

3.  Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.

Authors:  Juan Du; Ke Zhao; Yajuan Rui; Peng Li; Xiaohong Zhou; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

4.  Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.

Authors:  Kara Lukin; Scott Fields; Desiree Lopez; Marie Cherrier; Kristina Ternyak; Julita Ramírez; Ann J Feeney; James Hagman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

5.  HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.

Authors:  Lisa E Richter; Yiqian Wang; Michelle E Becker; Rachel A Coburn; Jacob T Williams; Catalina Amador; R Katherine Hyde
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

6.  Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells.

Authors:  Hiromi Tagoh; Roy Himes; Deborah Clarke; Pieter J M Leenen; Arthur D Riggs; David Hume; Constanze Bonifer
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

7.  Epigenetic consequences of AML1-ETO action at the human c-FMS locus.

Authors:  George A Follows; Hiromi Tagoh; Pascal Lefevre; Donald Hodge; Gareth J Morgan; Constanze Bonifer
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 8.  Runx3 knockouts and stomach cancer.

Authors:  Ditsa Levanon; Ori Brenner; Florian Otto; Yoram Groner
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

9.  Characterization of RNA aptamers that disrupt the RUNX1-CBFbeta/DNA complex.

Authors:  Jenny L Barton; David H J Bunka; Stuart E Knowling; Pascal Lefevre; Alan J Warren; Constanze Bonifer; Peter G Stockley
Journal:  Nucleic Acids Res       Date:  2009-09-09       Impact factor: 16.971

10.  Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.

Authors:  Dipayan Rudra; Takeshi Egawa; Mark M W Chong; Piper Treuting; Dan R Littman; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2009-09-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.